Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-2: Monthly IPTp-DP for Malaria in HIV-infected Pregnant Women
NCT04158713Phase 3Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Nov 2019
- Primary completion
- Apr 2022
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in malaria, sponsored by Liverpool School of Tropical Medicine. Started Nov 2019; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04158713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04158713.